Current Events

The most innovative Spanish projects of 2016 The most innovative Spanish projects of 2016

SOS Respira chosen among the most innovative Spanish projects of 2016

SOS Respira, the program to raise awareness on how to prevent choking by means of an app for mobile devices, promoted by Fundación MAPFRE, together with the Spanish Society of Emergency Medicine (SEMES) and the Federation of Cooks and Pastry Chefs of Spain (FACYRE), has been recognized as being among the 10 most innovative social initiatives of 2016 by CAF-Development Bank of Latin America and the magazine Compromiso Empresarial.

Drowning Prevention 2017 Drowning Prevention 2017

We are launching our new 'Drowning Prevention 2017' campaign

Do you take the correct safety precautions when bathing in the sea, swimming pools and lakes? Being knowledgeable about the type of water environment we find ourselves in and being careful is essential when bathing. Once again, Fundación MAPFRE is launching its summer campaign 'Drowning Prevention' so that you can enjoy the water safely.

Lecture series Lecture series play

Lecture Series 'Return to Beauty. Masterpieces of Italian art from between the wars'

If you liked our exhibition 'Return to Beauty. Masterpieces of Italian art from between the wars' or you are thinking of visiting us, you should not miss the series of lectures we have put together to provide you with a more in-depth knowledge of the Novecento Italiano, its artists and the return to order characterized by this period of the 20th century.

“Cell Therapy for disabilities with a neurological cause” can improve the quality of life of patients with traumatic spinal cord injuries “Cell Therapy for disabilities with a neurological cause” can improve the quality of life of patients with traumatic spinal cord injuries

“Cell Therapy for disabilities with a neurological cause” can improve the quality of life of patients with traumatic spinal cord injuries

Fundación MAPFRE has been helping to fund this research project with stem cells from when it started over twenty years ago. The results obtained following this first trial, which started in July 2013, are encouraging.